JBIO SCHEDULE 13G/A: SEC filing

Jade Biosciences, Inc.

Filed with the SEC on Aug 14, 2026 · accession 0001104659-26-096751

JBIO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. Jade Biosciences, Inc. (JBIO) filed an amended Schedule 13G (13G/A) with the SEC on 2026-08-14, indicating a change in a previously reported passive ownership position by an institutional holder. The stock moved +3.8% by the first close after the filing.

Summary of the filing

Jade Biosciences, Inc. (JBIO) filed an amended Schedule 13G (13G/A) with the SEC on 2026-08-14, indicating a change in a previously reported passive ownership position by an institutional holder. The filing text available does not disclose the specific holder, ownership percentage, or nature of the change.

For details, click here →

Key details

IssuerJade Biosciences, Inc.

How JBIO stock reacted

Close before

$23.81

Aug 13, 2026

First close after

+3.78%

$24.71

5 trading days

-10.84%

$21.23

Since filing

-36.71%

$15.07

✦ Ask GOAX AI about this filing — what it means for JBIO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for JBIO?

Click here

Frequently asked questions

What did JBIO file with the SEC on Aug 14, 2026?

JBIO filed a SCHEDULE 13G/A (SEC filing). Jade Biosciences, Inc. (JBIO) filed an amended Schedule 13G (13G/A) with the SEC on 2026-08-14, indicating a change in a previously reported passive ownership position by an institutional holder. The filing text available does not disclose the specific holder, ownership percentage, or nature of the change.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did JBIO stock react to this filing?

JBIO closed at $23.81 before the filing and $24.71 on Aug 14, 2026 (+3.78%). Five trading days later: $21.23 (-10.84%).

Other JBIO SEC filings

Get alerts when JBIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

JBIO overview JBIO analysis JBIO news Latest SEC filings